|
rs121913400
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
|
25373533 |
2015 |
|
rs121913400
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update.
|
23852704 |
2014 |
|
rs121913400
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Multitarget stool DNA testing for colorectal-cancer screening.
|
25006736 |
2014 |
|
rs121913400
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group.
|
24996433 |
2014 |
|
rs121913400
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
|
23429431 |
2013 |
|
rs121913400
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
|
23012255 |
2012 |
|
rs121913400
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
|
22855150 |
2012 |
|
rs121913400
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
|
22138009 |
2011 |
|
rs121913400
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
|
19042984 |
2008 |
|
rs121913400
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
|
17060676 |
2006 |
|
rs121913400
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
|
rs587776850
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
|
rs775104326
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
|
rs370662884
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In conclusion, CCND1 870G/A and CDH1 -160C/A SNPs may modify the risk of CRC susceptibility in South Indian population.
|
25146682 |
2014 |
|
rs370662884
|
|
|
0.020 |
GeneticVariation |
BEFREE |
However, the CCND1 G870A polymorphism may modify the protective effect of postmenopausal hormone use on the development of CRC.
|
18196581 |
2008 |
|
rs13072632
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We studied thirteen single nucleotide polymorphisms (SNPs) located in SFRP3 (rs7775), CTNNB1 (β-catenin) [rs4135385, rs13072632], APC (rs454886, rs459552), LRP6 (rs2075241, rs2284396), DKK4 (rs3763511), DKK3 (rs6485350), TCF4 (rs12255372) and AXIN2 (rs3923086, rs3923087, rs4791171) in patients with colorectal cancer (n = 122) and controls (n = 110).
|
31485167 |
2019 |
|
rs4135385
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We studied thirteen single nucleotide polymorphisms (SNPs) located in SFRP3 (rs7775), CTNNB1 (β-catenin) [rs4135385, rs13072632], APC (rs454886, rs459552), LRP6 (rs2075241, rs2284396), DKK4 (rs3763511), DKK3 (rs6485350), TCF4 (rs12255372) and AXIN2 (rs3923086, rs3923087, rs4791171) in patients with colorectal cancer (n = 122) and controls (n = 110).
|
31485167 |
2019 |
|
rs1233296947
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The CRC colorectal cancer (CRC) cell lines HCT116 wild-type (wt), HCT116 p53-/-, and HT-29 (mutant; R273H) were employed, covering three different p53 variations.
|
28618116 |
2017 |
|
rs139085081
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Here, we investigated, for the first time, the role of Arg324Gly (970C>G) along with Arg200Trp (598C>T) on colorectal cancer (CRC) risk by analyzing 659 patients and 607 control individuals drawn from the German DACHS (Darmkrebs: Chancen der Verhütung durch Screening) study.
|
17420170 |
2007 |